{"doi":null,"coreId":"11035","oai":"oai:etheses.bham.ac.uk:1475","identifiers":["oai:etheses.bham.ac.uk:1475",null],"title":"Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors","authors":["Das, Satyajit"],"enrichments":{"references":[{"id":406799,"title":"Accessed on 12\/12\/08). WHO,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":406803,"title":"AIDS due to HIV-2 infection--New Jersey. Can Dis Wkly Rep","authors":[],"date":"1988","doi":null,"raw":null,"cites":null},{"id":406800,"title":"HIV in the United Kingdom:","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":406801,"title":"HIV\/HTLV gene nomenclature.","authors":[],"date":null,"doi":"10.1038\/333504a0","raw":null,"cites":null},{"id":406804,"title":"Host factors and the pathogenesis of HIV-induced disease.","authors":[],"date":"1996","doi":"10.1038\/384529a0","raw":null,"cites":null},{"id":406807,"title":"Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.","authors":[],"date":null,"doi":null,"raw":null,"cites":null},{"id":406806,"title":"In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokinemediated suppression.","authors":[],"date":"1997","doi":null,"raw":null,"cites":null},{"id":406802,"title":"Nucleic acid structure and expression of the human AIDS\/lymphadenopathy retrovirus.","authors":[],"date":"1985","doi":"10.1038\/313450a0","raw":null,"cites":null},{"id":406805,"title":"receptor and a neutralizing human antibody.","authors":[],"date":"1998","doi":null,"raw":null,"cites":null},{"id":406798,"title":"Status of the global HIV epidemic.","authors":[],"date":"2008","doi":null,"raw":null,"cites":null}],"documentType":{"type":1}},"contributors":[],"datePublished":"2010-07","abstract":"The relationship between antiretroviral treatment of HIV infection, body fat distribution, insulin resistance (HOMA), adipocytokine and apolipoprotein-B (apoB) kinetics was investigated in 12 HIV negative controls and 55 HIV-infected patients including antiretroviral treatment-na\u00efve patients (n=15) and patients taking two nucleoside analogues plus either a protease inhibitor (PI, n=15) or non-nucleoside reverse transcriptase inhibitor (NNRTI, n = 25). The HIV positive treatment groups had mild dyslipidaemia. The apo-B fractional clearance rate (FCR) was reduced in the HIV positive groups. Peripheral fat was lower in treated patients and correlated with duration of therapy. There was a positive correlation between peripheral fat and apo-B clearance rate and a negative correlation with apo-B pool size. Adiponectin was reduced in all HIV positive groups and correlated positively with HDL-cholesterol, apo-B FCR and limb fat and correlated negatively with plasma triglycerides and HOMA. In a linear regression model which included HOMA, adiponectin level but not HOMA was predictive of apo-B FCR and HDL cholesterol. These results suggest that mild dyslipidaemia resulting from antiretroviral therapy is due to a decrease in apo-B FCR which is strongly related to loss of peripheral fat. Adiponectin may have a direct effect on lipoprotein metabolism which may be independent of insulin","downloadUrl":"https:\/\/core.ac.uk\/download\/pdf\/11035.pdf","fullTextIdentifier":"http:\/\/etheses.bham.ac.uk\/1475\/1\/Das_10_MD.pdf","pdfHashValue":"74abcb28108c3116fb6f3fd898615ea14092b587","publisher":null,"rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:etheses.bham.ac.uk:1475<\/identifier><datestamp>\n      2012-07-09T15:00:00Z<\/datestamp><setSpec>\n      7374617475733D756E707562<\/setSpec><setSpec>\n      7375626A656374733D52:5244<\/setSpec><setSpec>\n      7375626A656374733D52:5243<\/setSpec><setSpec>\n      74797065733D746865736973<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n    \n      \n        Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors<\/dc:title><dc:creator>\n        Das, Satyajit<\/dc:creator><dc:subject>\n        RD Surgery<\/dc:subject><dc:subject>\n        RC Internal medicine<\/dc:subject><dc:description>\n        The relationship between antiretroviral treatment of HIV infection, body fat distribution, insulin resistance (HOMA), adipocytokine and apolipoprotein-B (apoB) kinetics was investigated in 12 HIV negative controls and 55 HIV-infected patients including antiretroviral treatment-na\u00efve patients (n=15) and patients taking two nucleoside analogues plus either a protease inhibitor (PI, n=15) or non-nucleoside reverse transcriptase inhibitor (NNRTI, n = 25). The HIV positive treatment groups had mild dyslipidaemia. The apo-B fractional clearance rate (FCR) was reduced in the HIV positive groups. Peripheral fat was lower in treated patients and correlated with duration of therapy. There was a positive correlation between peripheral fat and apo-B clearance rate and a negative correlation with apo-B pool size. Adiponectin was reduced in all HIV positive groups and correlated positively with HDL-cholesterol, apo-B FCR and limb fat and correlated negatively with plasma triglycerides and HOMA. In a linear regression model which included HOMA, adiponectin level but not HOMA was predictive of apo-B FCR and HDL cholesterol. These results suggest that mild dyslipidaemia resulting from antiretroviral therapy is due to a decrease in apo-B FCR which is strongly related to loss of peripheral fat. Adiponectin may have a direct effect on lipoprotein metabolism which may be independent of insulin.<\/dc:description><dc:contributor.advisor>\n        Shahmanesh, Mohsen<\/dc:contributor.advisor><dc:contributor.advisor>\n        Waring, Rosemery<\/dc:contributor.advisor><dc:contributor.advisor>\n        Cramb, Rob<\/dc:contributor.advisor><dc:date>\n        2010-07<\/dc:date><dc:type>\n        Thesis<\/dc:type><dc:type>\n        NonPeerReviewed<\/dc:type><dc:format>\n        application\/pdf<\/dc:format><dc:identifier>\n        http:\/\/etheses.bham.ac.uk\/1475\/1\/Das_10_MD.pdf<\/dc:identifier><dc:relation>\n        public<\/dc:relation><dc:relation>\n        http:\/\/etheses.bham.ac.uk\/1475\/1.hassmallThumbnailVersion\/Das_10_MD.pdf<\/dc:relation><dc:identifier>\n        Das, Satyajit (2010) Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors. M.D. thesis, University of Birmingham.<\/dc:identifier><dc:relation>\n        http:\/\/etheses.bham.ac.uk\/1475\/<\/dc:relation><dc:language>\n        English<\/dc:language><dc:contributor.sponsor>\n        British Heart Foundation<\/dc:contributor.sponsor><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":{"code":"en","id":9,"name":"English"},"relations":["public","http:\/\/etheses.bham.ac.uk\/1475\/1.hassmallThumbnailVersion\/Das_10_MD.pdf","http:\/\/etheses.bham.ac.uk\/1475\/"],"year":2010,"topics":["RD Surgery","RC Internal medicine"],"subject":["Thesis","NonPeerReviewed"],"fullText":""}